Your session is about to expire
← Back to Search
Tech-Based Interventions for Suicide Risk in Adolescents
N/A
Recruiting
Led By Ewa Czyz
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
Study Summary
This trial is examining different ways to use technology to help identify people at risk for suicide after they leave the hospital.
Who is the study for?
This trial is for adolescents recently in psychiatric care due to a suicide attempt or having suicidal thoughts within the last week. They must be able to provide consent through a legal guardian, own a cell phone, and not have severe cognitive impairments or require transfer to medical care.Check my eligibility
What is being tested?
The study tests various tech-augmented strategies like portal follow-ups, safety planning with motivational interviewing (MI), booster calls, monitoring, and text messages. It aims to find an effective post-discharge plan that reduces suicide risk.See study design
What are the potential side effects?
Since this trial involves non-medical interventions focusing on communication and monitoring rather than drugs or medical procedures, traditional side effects are not applicable. However, participants may experience emotional discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The Columbia-Suicide Severity Rating Scale (C-SSRS)
Secondary outcome measures
C-SSRS will be used to assess the of time-to-suicidal behavior within 6 months of discharge
Suicidal Ideation Questionnaire-Junior (SIQ-JR)
Trial Design
6Treatment groups
Experimental Treatment
Group I: MI-SP +supportive Texts + monitoring (Sequence A)Experimental Treatment3 Interventions
Sequencing of intervention components (Phase 1 and Phase 2) resulting in Sequence or Group A: Participants will receive the in-person MI-enhanced safety plan (MI-SP) during hospitalization followed by 4 weeks of supportive Texts and monitoring post discharge.
Group II: MI-SP + supportive Texts + monitoring + portal follow-up for non-responders (Sequence B).Experimental Treatment4 Interventions
Sequencing of intervention components (Phase 1 and Phase 2) resulting in Sequence or Group B: Participants will receive the in-person MI-enhanced safety plan (MI-SP) during hospitalization followed by 4 weeks of supportive Texts and monitoring post discharge in addition to the portal follow-up for non-responders.
Group III: MI-SP + supportive Texts + monitoring + booster call for non-responders (Sequence C)Experimental Treatment4 Interventions
Sequencing of intervention components (Phase 1 and Phase 2) resulting in Sequence or Group C: Participants will receive the in-person MI-enhanced safety plan (MI-SP) during hospitalization followed by 4 weeks of supportive Texts and monitoring post discharge in addition to the booster call for non-responders.
Group IV: MI-SP + monitoring + portal follow-up for non-responders (Sequence E)Experimental Treatment3 Interventions
Sequencing of intervention components (Phase 1 and Phase 2) resulting in Sequence or Group E: Participants will receive the in-person MI-enhanced safety plan (MI-SP) during hospitalization followed by 4 weeks of monitoring post discharge in addition to the portal follow-up for non-responders.
Group V: MI-SP + monitoring + booster call for non-responders (Sequence F)Experimental Treatment3 Interventions
Sequencing of intervention components (Phase 1 and Phase 2) resulting in Sequence or Group F: Participants will receive the in-person MI-enhanced safety plan (MI-SP) during hospitalization followed by 4 weeks of monitoring post discharge in addition to the booster call for non-responders.
Group VI: MI-SP + monitoring (Sequence D)Experimental Treatment2 Interventions
Sequencing of intervention components (Phase 1 and Phase 2) resulting in Sequence or Group D: Participants will receive the in-person MI-enhanced safety plan (MI-SP) during hospitalization followed by 4 weeks of monitoring post discharge.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Monitoring
2010
Completed Phase 4
~960
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,797 Previous Clinical Trials
6,377,758 Total Patients Enrolled
18 Trials studying Suicide
11,345 Patients Enrolled for Suicide
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,467 Total Patients Enrolled
112 Trials studying Suicide
1,156,519 Patients Enrolled for Suicide
Ewa CzyzPrincipal InvestigatorUniversity of Michigan
2 Previous Clinical Trials
322 Total Patients Enrolled
2 Trials studying Suicide
322 Patients Enrolled for Suicide
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have a legal guardian.I am a teenager and I do not own a cell phone.I am a teenager with severe cognitive issues or experiencing a severe mental health crisis.You have attempted suicide in the past month or have had thoughts of suicide in the last week, as determined by a medical evaluation.I am being moved to a medical unit or residential care.
Research Study Groups:
This trial has the following groups:- Group 1: MI-SP + monitoring + portal follow-up for non-responders (Sequence E)
- Group 2: MI-SP + monitoring + booster call for non-responders (Sequence F)
- Group 3: MI-SP +supportive Texts + monitoring (Sequence A)
- Group 4: MI-SP + monitoring (Sequence D)
- Group 5: MI-SP + supportive Texts + monitoring + portal follow-up for non-responders (Sequence B).
- Group 6: MI-SP + supportive Texts + monitoring + booster call for non-responders (Sequence C)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who is eligible to participate in this trial?
"This clinical trial seeks to recruit 300 adolescent participants who have recently attempted suicide, or are exhibiting suicidal thoughts. Applicants must also match certain criteria; such as a recent suicide attempt in the last month, or evidence of past-week suicidal ideation (as indicated by C-SSRS scores). If these scores are not available on record, then physician's indication regarding presence of either within the last week will be accepted instead."
Answered by AI
Are participants aged 20 or above accepted in this experiment?
"The study's inclusion criteria stipulates that participants must be aged between 13 and 17 to take part."
Answered by AI
Is the research project currently enrolling participants?
"According to clinicaltrials.gov, this trial is not presently recruiting patients. The study was initially listed on November 1st 2022 and the last update occurred on the same date. However, there are 240 other medical studies that are currently looking for participants."
Answered by AI
Who else is applying?
What state do they live in?
Michigan
What site did they apply to?
University of Michigan's (Child and Adolescent Psychiatric Inpatient Program)
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
2
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger